4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-25-022520
Chief Financial Officer gave up 7,546 shares (to pay taxes)
- Chief Financial Officer acquired 19,371 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCombe William D. Chief Financial Officer | 2025-08-18 | Option exercise | +6,320 | 62,066 | D | ||
| McCombe William D. Chief Financial Officer | 2025-08-18 | Shares withheld for taxes | −2,462 | $4.06 | $9,996 | 59,604 | D |
| McCombe William D. Chief Financial Officer | 2025-08-18 | Option exercise | +13,051 | 72,655 | D | ||
| McCombe William D. Chief Financial Officer | 2025-08-18 | Shares withheld for taxes | −5,084 | $4.06 | $20,641 | 67,571 | D |
| Derivatives | |||||||
| McCombe William D. Chief Financial Officer | 2025-08-18 | Option exercise · Restricted Stock Units | −6,320 | 69,529 | D | ||
| McCombe William D. Chief Financial Officer | 2025-08-18 | Option exercise · Restricted Stock Units | −13,051 | 187,065 | D | ||
Loading xslF345X05/form4-08202025_090817.xml…